ArticleJournal for immunotherapy of cancer2022

Integrated use of PD-1 inhibition and transarterial chemoembolization for hepatocellular carcinoma: evaluation of safety and efficacy in a retrospective, propensity score-matched study.

Brett Marinelli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.